These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 19087842

  • 1. [The UPLIFT study: future perspectives].
    Rodríguez González-Moro JM, Lucero S, de Lucas Ramos P.
    Arch Bronconeumol; 2008; 44 Suppl 2():39-48. PubMed ID: 19087842
    [Abstract] [Full Text] [Related]

  • 2. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
    Tashkin DP.
    Am J Med; 2006 Oct; 119(10 Suppl 1):63-72. PubMed ID: 16996901
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM, White CM, Coleman CI.
    Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Tiotropium, a long-acting bronchodilating agent for the treatment of COPD].
    Schuurbiers OC, Schermer TR, Dekhuijzen PN, van Weel C.
    Ned Tijdschr Geneeskd; 2006 Jun 03; 150(22):1227-32. PubMed ID: 16796173
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tiotropium therapy and mortality risk in COPD patients: the most severe, the most protected? Evaluation of Celli B, Decramer M, Kesten S, et al. Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009; 180(10): 948-55.
    Sampablo I, Carone M, Antoniu SA.
    Expert Opin Pharmacother; 2010 Jun 03; 11(8):1439-41. PubMed ID: 20446856
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Tiotropium as new quality medication in the COPD management].
    Lubiński W, Płusa T.
    Pol Merkur Lekarski; 2006 Jan 03; 20(115):5-7. PubMed ID: 16617725
    [Abstract] [Full Text] [Related]

  • 18. The impact of severe exacerbations on quality of life and the clinical course of chronic obstructive pulmonary disease.
    Niewoehner DE.
    Am J Med; 2006 Oct 03; 119(10 Suppl 1):38-45. PubMed ID: 16996898
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. It's about time--directing our attention toward modifying the course of COPD.
    Cazzola M, Hanania NA, Jones PW, Mahler DA, Make B, Ohar J, Rennard S.
    Respir Med; 2008 Jun 03; 102 Suppl 1():S37-48. PubMed ID: 18582796
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.